Sera Prognostics, Inc. - Class A Common Stock (SERA)
3.3900
+0.2000 (6.27%)
NASDAQ · Last Trade: Apr 7th, 10:04 PM EDT
Detailed Quote
Previous Close
3.190
Open
3.000
Bid
3.040
Ask
3.360
Day's Range
2.990 - 3.440
52 Week Range
2.990 - 12.36
Volume
84,033
Market Cap
-
PE Ratio (TTM)
-
EPS (TTM)
-
Dividend & Yield
N/A (N/A)
1 Month Average Volume
105,546
Chart
About Sera Prognostics, Inc. - Class A Common Stock (SERA)
Sera Prognostics Inc is a biotechnology company focused on advancing maternal and fetal health through innovative diagnostic solutions. The company primarily develops predictive tests that aim to assess the risk of pregnancy complications, enabling healthcare providers to offer personalized care and interventions for expectant mothers and their babies. By harnessing advanced biomarker analysis and machine learning technologies, Sera Prognostics seeks to improve pregnancy outcomes and reduce healthcare costs associated with managing high-risk pregnancies. Their commitment to research and collaboration with healthcare professionals highlights their dedication to enhancing the overall well-being of mothers and infants. Read More
The Benzinga Stock Whisper Index highlights five stocks seeing increased interest from readers during the past week and a look at the reasons why and what's next.
Companies Reporting Before The Bell • UP Fintech Holding (NASDAQ:TIGR) is expected to report quarterly earnings at $0.07 per share on revenue of $207.00 million.
U.S. stocks traded mixed toward the end of trading on Wednesday. The Dow traded up 0.05% to 36,143.40 while the NASDAQ fell 0.06% to 14,221.51. The S&P 500 also fell, dropping, 0.05% to 4,564.73.
